Loading…
← CockpitCompetitor Analysis › BV BrightView Holdings, Inc.Open in the cockpit ↗

BrightView Holdings, Inc.BVCompetitor analysis, valuation and peers

United States · USD·Industrials›Miscellaneous Commercial Services
Momentum weak 22
Mkt cap
$803M
US dollars, full cap
Free float
73%
of shares outstanding
$/day
$14.0M
20-day average traded
Fwd P/E
19.6×
forward earnings
ROIC−WACC
-5.1 pp
WACC 7.8%
Hurdle
n/a
no reverse DCF
Next earnings
78 days
4 Feb 2027
Close · USD$8.81
1D+0.5%
1W-10.7%
1M-16.2%
3M-21.0%
6M-28.9%
YTD-30.5%
1Y-25.5%
ATR %6.4%
Beta0.84
52w lowhigh41.3% off high

What BrightView does

Employees: 17,700

BrightView at a glance

Size BrightView (BV) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $803M, the 2364th largest of 3,085 United States companies the cockpit tracks. Shares closed at $8.81 on 18 Nov 2026.

Performance Over six months the shares fell 28.9%, against -3.0% for the median peer and -2.2% for the United States market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue grew 1.5% over the last twelve months (peer median +5.2%); the operating margin is 3.5% (peer median 9.7%).

Valuation It trades at 19.6× forward earnings against a peer median of 17.7× (7th most expensive of 16).

Capital Return on invested capital runs 5.1 points below its cost of capital (7.8% WACC).

Backlog Backlog (remaining performance obligations) was $430M at 30 Sep 2026, down 7% on a year earlier — 0.2 years of trailing revenue. Backlog detail →

Short interest Short interest is 4.5% of the free float (30 Oct 2026).

Next results Next results expected around 4 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026Peer median 98BV 70
Six months, rebased to 100: BrightView against the median of its 20 peers (local-currency closes).

BrightView financials

Reported figures in USD; fiscal year ends 2026-09-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue$2.71B$2.71B$2.67B$2.77B$2.82B
Revenue growth—+1%-3%-2%—
Gross profit$532M$529M$593M$610M$634M
EBITDA$304M$308M$332M$302M$275M
Net income$1.00M$1.00M$56.0M$66.4M-$7.70M
Free cash flow-$40.3M-$40.3M$37.6M$125M$58.6M
Capital expenditure$225M$225M$254M$78.4M$71.3M
Total debt$1.09B$1.09B$950M$958M$1.02B

Quarterly statements and history in the cockpit →

BrightView competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%0%+20%688787MTRI9715KARTASK6033730009K0002649603955000561688530IPO688334IBEXAXISCADES3008609716001207CCLBV6-month return →1-month return →
Up and to the right = strong over both horizons. BrightView is the large dot.

Fundamentals: revenue growth against valuation

-40%-20%0%+20%+40%0×50×100×6887879715KARTASK603373002649IPO688334IBEX3008609716001207CCLBVRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. BrightView is the large dot.

BrightView competitors and peer comparison

How BrightView compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

BrightView against its 20 peers (data as of 18 Nov 2026)
MeasureBVPeer medianRank in peer set
1-month return-16.2%-4.2%4th lowest of 21
6-month return-28.9%-3.0%4th lowest of 21
Distance from 52-week high-41.3%-27.9%7th lowest of 21
Revenue growth (TTM)+1.5%+5.2%8th lowest of 21
Operating margin3.5%9.7%6th lowest of 21
Forward P/E19.6×17.7×7th most expensive of 16
ROIC minus cost of capital-5.1 pp+3.1 pp7th lowest of 19
EV / EBITDA7.9×10.6×3rd cheapest of 10
Net debt / EBITDA3.6×-0.8×most indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
BrightView BVUnited States$803M-29%+1%4%19.6×n/an/a
Beijing Haitian Ruisheng Science Technology 688787.SSChina$801M-37%+34%4%126.5×n/an/a
Mentari Therapeutics MTRIUnited States$807M-91%-83%-1,239%n/an/an/a
transcosmos 9715.TJapan$814M-11%+6%4%10.1×-18.2%+3.2%
Karnov KAR.STSweden$820M+9%-4%20%20.6×5.1%+27.9%
TaskUs TASKUnited States$827M+50%+9%12%6.5×1.3%+19.9%
Anbang Save-Guard 603373.SSChina$779M+6%-1%14%38.9×5.6%+5.6%
Aimed Bio 0009K0.KSSouth Korea$778M-61%+228%34%n/a10.2%+652.2%
Beyondsoft 002649.SZChina$769M-14%-6%2%24.1×7.0%+9.2%
Daqian Ecology & Environment 603955.SSChina$769M+21%+217%-53%n/an/an/a
Shaanxi Fenghuo Electronics 000561.SZChina$851M-27%+8%-26%n/an/an/a
Omat Advanced Materials (Guangdong) 688530.SSChina$757M-19%+82%9%n/an/an/a
IP Group plc IPO.LUnited Kingdom$865M+11%-37%51%12.0×n/an/a
Xi'an High Voltage Apparatus Research Institute 688334.SSChina$866M-11%+4%29%20.7×-2.9%+20.3%
IBEX IBEXUnited States$744M+79%+15%9%13.5×1.0%+7.7%
AXISCADES Technologies AXISCADES.NSIndia$871M-6%+5%10%17.7×n/an/a
Funshine Culture 300860.SZChina$739M0%-49%-35%24.2×21.5%-24.6%
NOMURA 9716.TJapan$880M+7%-10%7%14.6×-7.5%+8.6%
Shandong Link Science and Technology 001207.SZChina$733M-24%+7%13%11.6×-5.5%+18.9%
Cuscal CCL.AXAustralia$728M+17%+19%12%18.1×n/an/a
Funai Soken 9757.TJapan$724M+10%+5%25%16.2×-8.7%+5.9%

BrightView backlog

BrightView reported $430M of remaining performance obligations at 30 Sep 2026, down 7% from a year earlier and down 4% from the previous quarter. That is 0.2 years of trailing revenue already under contract. Book-to-bill last quarter: 0.98.

Questions

Which companies are BrightView's closest peers?
The cockpit's peer set: Beijing Haitian Ruisheng Science Technology (688787.SS), Mentari Therapeutics (MTRI), transcosmos (9715.T), Karnov (KAR.ST), TaskUs (TASK), Anbang Save-Guard (603373.SS), Aimed Bio (0009K0.KS), Beyondsoft (002649.SZ).
Is BrightView expensive compared with its peers?
On forward p/e it trades at 19.6× against a peer median of 17.7×, 7th most expensive of 16 in its peer set.
How has BrightView stock performed?
Over six months to 18 Nov 2026 the shares returned -28.9% against -3.0% for the median peer; over one year -25.5%.
What is BrightView's backlog?
BrightView's remaining performance obligations (contracted revenue not yet recognised) were $430M at 30 Sep 2026, -7% on a year earlier.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.